Partnerships - ARMI & NIMBL
The Cal Poly Regenerative Medicine Program has partnered up with ARMI and NIMBL. The goal of both of the organizations is to support the development of technologies and processes that allow the large scale manufacturing of gene (NIIMBL), cell (NIIMBL), and tissue (ARMI) therapies.
ARMI integrates innovative cell and tissue cultures with advances in biofabrication, automation, robotics, and analytical technologies to create disruptive research and development tools and FDA-compliant volume manufacturing processes.
For more Information, visit their website.
NIIMBL is working to enable more efficient and flexible manufacturing capabilities for existing and emerging biopharmaceutical products, and develop a world-leading biopharmaceutical manufacturing workforce. For more information, visit their website.